Welcome to the new associate Editor-in-Chief of memo Wolfgang HilbeWaltraud Radlherr editorial 31 August 2016 Pages: 105 - 105
A welcome statement from the associate Editor-in-Chief Rupert Bartsch editorial 31 August 2016 Pages: 106 - 106
Rationale of an economically driven PD1 biomarker development in lung cancer—an academic dilemma Wolfgang HilbeRupert BartschChristoph Zielinski editorial 29 August 2016 Pages: 109 - 110
Novel strategies in the management of chronic lymphocytic leukemia (CLL) Daniel Heintel special report 19 September 2016 Pages: 111 - 115
Acute myeloid leukemia: highlights from ASH 2015 Michael Pfeilstöcker short review 27 July 2016 Pages: 116 - 119
Indolent lymphoma at ASH 2015: new treatment approaches Thomas Nösslinger short review 23 August 2016 Pages: 120 - 123
Practice changing information in aggressive lymphoma, ASH 2015 Michael A. Fridrik short review 20 July 2016 Pages: 124 - 126
Reversal of direct oral anticoagulants in hemophilia treatment Clemens FeistritzerStefan Schmidt short review Open access 12 September 2016 Pages: 131 - 135
Antiangiogenic therapies in ovarian cancer Alexander Reinthaller short review Open access 15 September 2016 Pages: 139 - 143
Healthcare resource utilization and G‑CSF use in patients with solid tumors or hematological malignancies hospitalized for febrile neutropenia in Bulgaria, Czech Republic and Slovakia Georgi MihaylovZhasmina MihaylovaRoumyana Petrova original report 19 September 2016 Pages: 144 - 152